BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1344829)

  • 1. [Dominant polycystic renal disease. Study of 105 cases].
    Kheder A; Ben Hamida F; el Younsi F; Abderrahim E; Safar M; Ben Ayed H; Ben Maiz H
    Rev Med Interne; 1992; 13(5):345-8. PubMed ID: 1344829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension in polycystic kidney disease type 1 and 2 and its effect on the age of onset of end-stage renal disease.
    Torra R; Badenas C; Pérez L; Estivill X; Darnell A
    Contrib Nephrol; 1997; 122():28-30. PubMed ID: 9399033
    [No Abstract]   [Full Text] [Related]  

  • 3. Association of the ACE gene polymorphism with the progression of autosomal dominant polycystic kidney disease.
    Lee KB; Kim UK; Lee CC
    J Korean Med Sci; 2000 Aug; 15(4):431-5. PubMed ID: 10983692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case from practice (278). Familial polycystic kidney disease, adult type: increasing kidney insufficiency. Renal hypertension. Renal anemia].
    Fuhrimann P
    Schweiz Rundsch Med Prax; 1993 Sep; 82(39):1081-2. PubMed ID: 8210874
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical view of autosomal dominant polycystic kidney disease].
    Rózański J; Myślak M; Domański L; Ciechanowski K; Szmatłoch E
    Pol Arch Med Wewn; 2000 Aug; 104(2):525-31. PubMed ID: 11303321
    [No Abstract]   [Full Text] [Related]  

  • 6. Autosomal dominant polycystic kidney disease and hypertension in the aviator.
    Fox KA; Rudge FW
    Aviat Space Environ Med; 1996 Apr; 67(4):376-8. PubMed ID: 8900993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Renal manifestation of Autosomal Dominant Polycystic Kidney Disease].
    Galliani M; Chicca S; Vitaliano E; Di Lullo L; Giannakakis K; Paone A
    G Ital Nefrol; 2018 Mar; 35(2):. PubMed ID: 29582957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affected parent sex and severity of autosomal dominant polycystic kidney disease: a retrospective cohort study
.
    Nowak KL; Chonchol M; You Z; Gupta M; Gitomer B
    Clin Nephrol; 2018 Mar; 89(3):196-204. PubMed ID: 29035198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertension in individuals at risk for autosomal dominant polycystic kidney disease: to screen or not to screen?
    Perrone RD; Miskulin DC
    Am J Kidney Dis; 2005 Sep; 46(3):557-9. PubMed ID: 16129219
    [No Abstract]   [Full Text] [Related]  

  • 10. Outcome of Kidney Transplant in Patients with Polycystic Kidney Disease: A Single-Center Study in Tunisia.
    Barbouch S; Hajji M; Hedri H; El Younsi F; Ben Hamida F; Bacha MM; Ounissi M; Abderrahim E; Ben Abdallah T
    Exp Clin Transplant; 2017 Feb; 15(Suppl 1):196-199. PubMed ID: 28260467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic and renal manifestations in autosomal dominant polycystic kidney disease: a dichotomy of two ends of a spectrum.
    van Gulick JJ; Gevers TJ; van Keimpema L; Drenth JP
    Neth J Med; 2011 Sep; 69(9):367-71. PubMed ID: 21978978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticipation of end-stage renal disease in autosomal dominant polycystic kidney disease.
    Gonzalo A; Gallego A; San Millan JL; Ortuño J
    Nephrol Dial Transplant; 1996; 11 Suppl 6():21-3. PubMed ID: 9044323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autosomal dominant polycystic kidney disease: pathophysiology and treatment.
    McCarthy S; McMullen M
    ANNA J; 1997 Feb; 24(1):45-51; quiz 52-3. PubMed ID: 9146123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Autosome dominant polycystic kidney disease. Leading symptoms: arterial hypertension, flank/back/abdominal pain, hematuria, renal failure].
    Kolyvanos Naumann U; Käser L; Vetter W
    Praxis (Bern 1994); 2004 Nov; 93(48):1993-7; quiz 1998. PubMed ID: 15603309
    [No Abstract]   [Full Text] [Related]  

  • 15. [Two cases of autosomal dominant polycystic kidney diseases who presented bilateral enlarged kidneys and severe hypertension in the neonatal period].
    Wakaki H; Ikeda M; Hataya H; Ishikura K; Nakashima T; Oosako Y; Honda M
    Nihon Jinzo Gakkai Shi; 2004 Oct; 46(7):719-23. PubMed ID: 15570901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Autosomal dominant polycystic kidney disease (ADPKD). in Morocco. Multicenter study about 308 families].
    Bourquia A;
    Nephrologie; 2002; 23(2):93-6. PubMed ID: 12012754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genesis and significance of hypertension in autosomal dominant polycystic kidney disease.
    Zeier M; Ritz E; Geberth S; Gonzalo A
    Nephron; 1994; 68(2):155-8. PubMed ID: 7830851
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical management of autosomal dominant polycystic kidney disease.
    Bennett WM; Elzinga LW
    Kidney Int Suppl; 1993 Jul; 42():S74-9. PubMed ID: 8361135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Autosomal dominant polycystic kidney disease in infancy].
    Kuwertz-Bröking E; Rabe H; Grande B; Bulla M
    Klin Padiatr; 1991; 203(5):381-3. PubMed ID: 1942947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of hypertension according to phenotype and gender in autosomal-dominant polycystic kidney disease.
    Boulahrouz R; Mazeau P; Charasse C; Catroux B; Le Cacheux P; Ang KS; Simon P
    Contrib Nephrol; 1997; 122():17-21. PubMed ID: 9399031
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.